Detalles de la búsqueda
1.
Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.
J Am Soc Nephrol
; 32(11): 2725-2727, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716240
2.
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients.
Kidney Int
; 100(3): 698-700, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34273381
3.
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease.
Kidney Int
; 100(6): 1335-1337, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34619233
Resultados
1 -
3
de 3
1
Próxima >
>>